OR WAIT null SECS
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters.
SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.
April 17, 2024
Webinar Date/Time: Thu, May 16, 2024 11:00 AM EDT
April 02, 2024
Increases in efficiencies, flexibility, scalability, and sustainability are impacting adoption.
April 01, 2024
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 25, 2024
Webinar Date/Time: Thu, Thu, Apr 18, 2024 11:00 AM EDT
March 21, 2024
Webinar Date/Time: Wed, May 8, 2024 11:00 AM EDT
March 02, 2024
February 21, 2024
Webinar Date/Time: Wed, Mar 20, 2024 11:00 AM EDT
February 16, 2024
Webinar Date/Time: Thu, Mar 21, 2024 11:00 AM EDT
February 07, 2024
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.
February 02, 2024
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters, including for enhanced upstream processes such as those incorporating high cell density perfusion.